Infectious Disease Program
Undisclosed Viral Targets
Key Facts
About Lipo-Immuno Tech
Founded in 2020 and based in Cambridge, USA, Lipo-Immuno Tech is a private, pre-clinical stage biotech leveraging a versatile lipid nanoparticle (LNP) delivery platform to create novel immunotherapies. The company is advancing a pipeline of programs targeting solid tumors and infectious diseases, with its lead oncology candidate expected to enter clinical trials in the near term. Its strategy involves both internal development and strategic partnerships to expand the application of its platform. The company is positioned in the high-growth fields of immuno-oncology and mRNA therapeutics, capitalizing on the proven success of LNP technology.
View full company profileAbout Cutanos
Cutanos is a private, preclinical-stage biotech founded in 2020 in Vienna, Austria, focused on a first-of-its-kind targeted delivery platform for mRNA therapeutics. Its proprietary Langerhans Cell Targeted Delivery System (LC-TDS) utilizes a ligand to specifically target a key subset of skin-resident dendritic cells, aiming to enhance vaccine efficacy while reducing doses and side effects. The company is leveraging its modular platform to develop next-generation vaccines and is supported by Austrian public funding agencies and experienced biotech advisors. Cutanos operates as a platform company, positioning its technology for applications in infectious diseases, oncology, and potentially autoimmune disorders.
View full company profileAbout Electrome
Electrome is positioning itself as a category leader in the emerging field of bioelectric medicine. Its core strategy involves an integrated platform combining a proprietary AI-powered discovery engine, a bioelectric data knowledge graph, and a modular hardware system to rapidly develop and commercialize non-invasive electroceuticals. With a first therapy for pain and inflammation prepared for launch via a 510(k) regulatory path, the company aims for near-term revenue while building a pipeline across high-burden diseases like wound healing, infectious disease, and oncology.
View full company profile